Spectrum Pharmaceuticals (SPPI)
Spectrum Pharmaceuticals Cash and ST Investments: 186.32M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SPPI Cash and ST Investments Rankings
| Overall | 66th percentile | 1480 of 4370 |
| Sector | 76th percentile | 119 of 506 in Healthcare |
| Industry | 78th percentile | 34 of 160 in Biotechnology |
SPPI Cash and ST Investments Range, Past 5 Years
| Minimum | 48.59M | Mar 2008 |
| Maximum | 186.32M | Mar 2012 |
| Average | 93.15M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these SPPI related companies
SPPI News
From those, I only hold $AMRN... lots of it, really. But I won't touch $SPPI unless I see $10.5 or lower.
about 2 hours ago by mitrado
about 2 hours ago by mitrado
$AMRN, $SPPI, $KERX Any concerns about Friday Jobs report? Holding-selling-buying? http://stks.co/43Ed
about 3 hours ago by JasonMilano8
about 3 hours ago by JasonMilano8
@Bleedblue Loool. Basic english u r not understanding @Tarek307-how is ur day. Made 5times money today $AMRN. Tomorrow play $SPPI
about 2 days ago by SamRocks
about 2 days ago by SamRocks
@JasonMilano8 I was waiting for a dip in $SPPI, I got 50 shares of $SDRL instead. Nice dividend, while I'll keep waiting for $SPPI to dip.
about 2 days ago by mitrado
about 2 days ago by mitrado
$AMRN will buy at $10.55, $KERX will buy at $1.66, $SPPI will buy at $10.75
about 2 days ago by JasonMilano8
about 2 days ago by JasonMilano8
$AMRN performs worst after a patent confirmation than $SPPI does, after starting a Phase 1 test!? Ridiculous.
about 2 days ago by mitrado
about 2 days ago by mitrado
$SPPI announced the initiation of patient enrollment in a Phase - 1 clinical trial evaluating the safety & tolerability of RenaZorb.
about 2 days ago by ANDISIK
about 2 days ago by ANDISIK
Should have sold more of my $AIS, Why ? Bought $SPPI on 5/23/12 at $10.76 & on 5/29/12 at 10:24 am. its $11.69, up 8.7%.
about 2 days ago by ANDISIK
about 2 days ago by ANDISIK
@mitrado I hear ya, I've been waiting for a dip in $SPPI as well.....
about 2 days ago by chesty1
about 2 days ago by chesty1
@chesty1 Yes, day traders were waiting to sell near $12. They got it, they dumped it. Why can't this happen in $SPPI or $SDRL? I need a dip.
about 2 days ago by mitrado
about 2 days ago by mitrado
Spectrum Pharmaceuticals Announces Enrollment of First Group of Patients in Phase 1 Clinical Trial of RenaZorb®
May 29, 7:00AM Business Wire
May 29, 7:00AM Business Wire
Markets are going to be pretty messed for a while. Even so, I got a few more $AMRN on this dip. I'm watching $SPPI too. Looks very solid.
about 5 days ago by mitrado
about 5 days ago by mitrado
$SPPI And the stock has around a 50% short ratio. Is there some massive insider leakage or just over-zealous shorting due to PIII failure?
about 6 days ago by Glopolon
about 6 days ago by Glopolon
$SPPI Earnings were great in Q1, and forward outlook is also positive for Fusilev, deal for $ALTH is closing soon, so Folotyn is on the way.
about 6 days ago by Glopolon
about 6 days ago by Glopolon
$SPPI I know you short on news of a failed trial, Apaz., but typically that works really well on a company without other sources of revenue.
about 6 days ago by Glopolon
about 6 days ago by Glopolon
@Glopolon I think I'll wait a bit more on $SPPI. Hope it doesn't run away from me like $HGSI did.
about 6 days ago by mitrado
about 6 days ago by mitrado
$SPPI So, um, yeah, 50% of the float is short, on a company with no debt and decent profits. Mind boggling stuff.
about 7 days ago by Glopolon
about 7 days ago by Glopolon
@ANDISIK Don't worry. In these markets, $SPPI will drop again. I'm still waiting for $10 - $10.5 to get in.
about 7 days ago by mitrado
about 7 days ago by mitrado
Only put 45 thousand into $SPPI yesterday. Wish I had doubled or tripled that amount.
about 7 days ago by ANDISIK
about 7 days ago by ANDISIK
RT @JasonMilano8 $KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.LOL to early out
about 7 days ago by dkcba007
about 7 days ago by dkcba007
@JasonMilano8, Where do see the $SPPI share price in 2-3 weeks going to ??
about 7 days ago by ANDISIK
about 7 days ago by ANDISIK
$KERX, $AMRN, $SPPI sold and completely out until mid june. stock will be much cheaper in 2-3 weeks.
about 7 days ago by JasonMilano8
about 7 days ago by JasonMilano8
@casualtrader, $AIS. You should check out $SPPI, great company. I actually got back in today. ·
about 8 days ago by ANDISIK
about 8 days ago by ANDISIK
Allos (ALTH) Sees Increased Volatility; FTC Requests More Info on Merger with Spectrum (SPPI)
May 10, 9:44AM Street Insider
May 10, 9:44AM Street Insider
Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 08, 7:00AM Business Wire
May 08, 7:00AM Business Wire
Spectrum Pharmaceuticals to Present at the Deutsche Bank 37th Annual Health Care Conference
May 01, 7:00AM Business Wire
May 01, 7:00AM Business Wire
Spectrum Pharmaceuticals Reports Record Revenues and Profits for First Quarter of 2012
Apr 26, 7:00AM Business Wire
Apr 26, 7:00AM Business Wire
Tang Capital Management Raises Stake in Spectrum Pharmaceuticals, Inc. (SPPI) to 7.72%
Apr 23, 9:26AM Street Insider
Apr 23, 9:26AM Street Insider
Spectrum Pharmaceuticals Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV®
Apr 23, 7:00AM Business Wire
Apr 23, 7:00AM Business Wire
Spectrum Pharmaceuticals Announces First Quarter 2012 Financial Results Teleconference and Webcast
Apr 17, 7:00AM Business Wire
Apr 17, 7:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPPI | 11.56 | -0.23 | -1.99% | 698.79M |
| SPP | 3.16 | -0.13 | -3.95% | 1.646B |
| SPNS | 3.90 | -0.08 | -2.01% | 154.75M |
| SPN | 21.63 | +0.00 | +0.00% | 3.409B |
| SPMD | 2.62 | +0.02 | +0.77% | 40.22M |
| SPLS | 13.24 | -0.13 | -0.97% | 9.251B |
| SPIR | 0.7502 | -0.04 | -5.04% | 6.762M |
| SPIL | 5.285 | +0.01 | +0.28% | 3.264B |
| SPH | 36.71 | -0.27 | -0.73% | 1.313B |
| SPG | 148.11 | +1.93 | +1.32% | 43.53B |